A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets
Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2015.00197
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 11, 2015
Authors
Publisher
Frontiers Media SA